2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on Pancreatic Cancer: Perioperative Chemotherapy + mFOLFIRINOX vs. Gemcitabine/nab-Paclitaxel - Which Option Provides More Benefit for Resectable Pancreatic Ductal Adenocarcinoma?

0 views
August 13, 2020
Comments 0
Login to view comments. Click here to Login